tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

NRSN Stock Latest News

NeuroSense Therapeutics Reports Key Progress and Financials
Company AnnouncementsNeuroSense Therapeutics Reports Key Progress and Financials
16d ago
NRSN
NeuroSense Regains Nasdaq Compliance, Strengthens Position for ALS Treatment
PremiumCompany Announcements
NeuroSense Regains Nasdaq Compliance, Strengthens Position for ALS Treatment
25d ago
6K
NRSN
NeuroSense regains Nasdaq compliance
PremiumThe Fly
NeuroSense regains Nasdaq compliance
25d ago
NRSN
NeuroSense files to sell 5.28M ordinary shares for holders
PremiumThe Fly
NeuroSense files to sell 5.28M ordinary shares for holders
1M ago
NRSN
NeuroSense Partners with Pharma Giant to Propel ALS Drug PrimeC
PremiumCompany Announcements
NeuroSense Partners with Pharma Giant to Propel ALS Drug PrimeC
1M ago
6K
NRSN
NeuroSense enters binding term sheet to advance PrimeC for ALS
PremiumThe FlyNeuroSense enters binding term sheet to advance PrimeC for ALS
1M ago
NRSN
NeuroSense Advances ALS Treatment with PrimeC, Boosts Financial Position
Premium
Company Announcements
NeuroSense Advances ALS Treatment with PrimeC, Boosts Financial Position
1M ago
6K
NRSN
NeuroSense reports first nine months EPS (48c) vs. (55c) last year
Premium
The Fly
NeuroSense reports first nine months EPS (48c) vs. (55c) last year
1M ago
NRSN
NeuroSense Therapeutics Regains Nasdaq Compliance
PremiumCompany Announcements
NeuroSense Therapeutics Regains Nasdaq Compliance
1M ago
6K
NRSN
NeuroSense cut to Hold at Maxim following PrimeC FDA feedback
PremiumThe Fly
NeuroSense cut to Hold at Maxim following PrimeC FDA feedback
2M ago
NRSN
NeuroSense downgraded to Hold from Buy at Maxim
PremiumThe Fly
NeuroSense downgraded to Hold from Buy at Maxim
2M ago
NRSN
NeuroSense Receives FDA Approval for Phase 3 Study of ALS Treatment
PremiumCompany Announcements
NeuroSense Receives FDA Approval for Phase 3 Study of ALS Treatment
2M ago
6K
NRSN
NeuroSense concludes Type C meeting with FDA for PrimeC treatment
PremiumThe FlyNeuroSense concludes Type C meeting with FDA for PrimeC treatment
2M ago
NRSN
NeuroSense files to sell 6.6M ordinary shares for holders
Premium
The Fly
NeuroSense files to sell 6.6M ordinary shares for holders
2M ago
NRSN
NeuroSense’s PrimeC Shows Promise in ALS Treatment
Premium
Company Announcements
NeuroSense’s PrimeC Shows Promise in ALS Treatment
2M ago
6K
NRSN
NeuroSense announces ‘positive’ results from the PARADIGM study
PremiumThe Fly
NeuroSense announces ‘positive’ results from the PARADIGM study
2M ago
NRSN
NeuroSense Therapeutics Announces Securities Purchase Agreement
PremiumCompany Announcements
NeuroSense Therapeutics Announces Securities Purchase Agreement
2M ago
6K
NRSN
NeuroSense Therapeutics Secures Continued Nasdaq Listing
PremiumCompany Announcements
NeuroSense Therapeutics Secures Continued Nasdaq Listing
3M ago
6K
NRSN
Neurosense Therapeutics Secures $30 Million Equity Deal
PremiumCompany Announcements
Neurosense Therapeutics Secures $30 Million Equity Deal
3M ago
6K
NRSN
NeuroSense Completes Key ALS Trial Phase
PremiumCompany AnnouncementsNeuroSense Completes Key ALS Trial Phase
3M ago
6K
NRSN
NeuroSense Therapeutics Advances ALS Drug Development Plans
Premium
Company Announcements
NeuroSense Therapeutics Advances ALS Drug Development Plans
3M ago
6K
NRSN
NeuroSense to meet with FDA for Phase 3 ALS trial and NDA submission
Premium
The Fly
NeuroSense to meet with FDA for Phase 3 ALS trial and NDA submission
3M ago
NRSN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >